Macquarie Group’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,047	Closed	-$5.21K	–	1722
2024 Q3	$5.21K	Buy	+1,047	New	+$5.21K	﹤0.01%	1636
2024 Q2	–	Sell	-1,618	Closed	-$13	–	2137
2024 Q1	$13	Buy	+1,618	New	+$13	﹤0.01%	1713